UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Rural Livelihoods in China: Political economy in transition

Zhang, Heather Xiaoquan

1, 2015

Volltextzugriff (PDF)

PB1926: EFFICACY AND SAFETY OF ONCE DAILY (QD) VS TWICE DAILY (BID) ZANUBRUTINIB FOR PATIENTS WITH VARIOUS B-CELL MALIGNANCIES: A COMPARATIVE SUMMARY OF CLINICAL DATA AND EXPOSURE-RESPONSE ANALYSES

HemaSphere, 2023-08, Vol.7 (S3), p.e70124b5

2023

Volltextzugriff (PDF)

In vitro investigations into the roles of CYP450 enzymes and drug transporters in the drug interactions of zanubrutinib, a covalent Bruton's tyrosine kinase inhibitor

Pharmacology research & perspectives, 2021-12, Vol.9 (6), p.e00870-n/a

2021

Volltextzugriff (PDF)

Prediction of bictegravir human pharmacokinetics from protein binding and in vitro-in vivo correlation

Drug metabolism and pharmacokinetics, 2018-01, Vol.33 (1), p.S26-S27

2018

Volltextzugriff (PDF)

Design and synthesis of highly selective, orally active Polo-like kinase-2 (Plk-2) inhibitors

Bioorganic & medicinal chemistry letters, 2013-05, Vol.23 (9), p.2743-2749

2013

Volltextzugriff (PDF)

Antiviral Activity, Safety, and Pharmacokinetics of Bictegravir as 10-Day Monotherapy in HIV-1-Infected Adults

Journal of acquired immune deficiency syndromes (1999), 2017-05, Vol.75 (1), p.61-66

2017

Volltextzugriff (PDF)

Migration in a transitional economy: Beyond the planned and spontaneous dichotomy in Vietnam

Geoforum, 2006-11, Vol.37 (6), p.1066-1081

2006

Volltextzugriff (PDF)

PB1926: EFFICACY AND SAFETY OF ONCE DAILY (QD) VS TWICE DAILY (BID) ZANUBRUTINIB FOR PATIENTS WITH VARIOUS B‐CELL MALIGNANCIES: A COMPARATIVE SUMMARY OF CLINICAL DATA AND EXPOSURE‐RESPONSE ANALYSES

HemaSphere, 2023-08, Vol.7, p.n/a

2023

Volltextzugriff (PDF)

The gathering storm: AIDS policy in China

Journal of international development, 2004-11, Vol.16 (8), p.1155-1168

Xiaoquan Zhang, Heather

2004

Volltextzugriff (PDF)

Co-operative financial institutions and local development in China

Journal of co-operative organization and management, 2015-06, Vol.3 (1), p.32-39

2015

Volltextzugriff (PDF)

Human and nonclinical disposition of [14C]bictegravir, a potent integrase strand-transfer inhibitor for the treatment of HIV-1 infection

Xenobiotica, 2022-11, Vol.52 (9-11), p.973-985

2022

Volltextzugriff (PDF)

Human pharmacokinetics prediction with an in vitro-in vivo correction factor approach and in vitro drug-drug interaction profile of bictegravir, a potent integrase-strand transfer inhibitor component in approved biktarvy® for the treatment of HIV-1 infection

Xenobiotica, 2022-12, Vol.52 (12), p.1020-1030

2022

Volltextzugriff (PDF)

Urban education differentiation and its socio-economic consequences: An internet–survey-based structural equation modeling analysis of new white collar workers in Nanjing, China

Research in social stratification and mobility, 2017-04, Vol.48, p.1-9

2017

Volltextzugriff (PDF)

Guest Editor’s Preface

Journal of current Chinese affairs, 2009-12, Vol.38 (4), p.3-7

Zhang, Heather Xiaoquan

2009

Volltextzugriff (PDF)

Protecting Mobile Livelihoods: Actors' Responses to the Emerging Health Challenges in Beijing and Tianjin

Modern China, 2012-07, Vol.38 (4), p.446-478

Zhang, Heather Xiaoquan

2012

Volltextzugriff (PDF)

Abstract CT189: A first-in-human, phase 1a, dose-escalation study of BGB-10188, a phosphatidylinositol 3-kinase delta (PI3Kδ) inhibitor, + tislelizumab (anti-PD-1) in patients with solid tumors

Cancer research (Chicago, Ill.), 2024-04, Vol.84 (7_Supplement), p.CT189-CT189

2024

Volltextzugriff (PDF)

The role of apoptosis in the development and function of T lymphocytes

Cell research, 2005-10, Vol.15 (10), p.749-769

2005

Volltextzugriff (PDF)

Human Mass Balance and Metabolite Profiling of [14C]‐Pamiparib, a Poly (ADP‐Ribose) Polymerase Inhibitor, in Patients With Advanced Cancer

Clinical pharmacology in drug development, 2021-09, Vol.10 (9), p.1108-1120

2021

Volltextzugriff (PDF)

Comparisons of the success of racial minority immigrant offspring in the United States, Canada and Australia

Social science research, 2011-07, Vol.40 (4), p.1051-1066

2011

Volltextzugriff (PDF)

P176 Clinical pharmacology of the HIV integrase strand transfer inhibitor bictegravir

Sexually transmitted infections, 2017-06, Vol.93 (Suppl 1), p.A74-A74

2017

Volltextzugriff (PDF)

Working with the homeless: The case of a non-profit organisation in Shanghai

Local economy, 2012-06, Vol.27 (4), p.373-387

2012

Volltextzugriff (PDF)

Safety, efficacy, and pharmacokinetics of single-tablet elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide in virologically suppressed, HIV-infected children: a single-arm, open-label trial

The lancet child & adolescent health, 2017-09, Vol.1 (1), p.27-34

2017

Volltextzugriff (PDF)

THE ANTI-ISCHEMIC EFFECT OF RANOLAZINE CLOSELY PARALLELS ITS QTC-SHORTENING EFFECT IN PATIENTS WITH LONG-QT SYNDROME 3

Journal of the American College of Cardiology, 2013-03, Vol.61 (10), p.E1176-E1176

2013

Volltextzugriff (PDF)

Pharmacokinetic drug-drug interaction study of ranolazine and metformin in subjects with type 2 diabetes mellitus

Clinical pharmacology in drug development, 2015-03, Vol.4 (2), p.121-129

2015

Volltextzugriff (PDF)

Towards a More Systematic and International Economic Sociology

Asian Journal of Social Science, 2007-01, Vol.35 (2), p.258-265

Heather, Zhang

2007

Volltextzugriff (PDF)

1 – 25 von 2.606

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(2.420)
Mit Volltextzugriff
(2.290)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.698)
Life Sciences & Biomedicine
(1.310)
Humans
(920)
Female
(491)
Animals
(441)
Male
(421)
Mice
(287)
Adult
(247)
Middle Aged
(230)
Physical Sciences
(223)
Oncology
(204)
Science & Technology - Other Topics
(193)
Biological And Medical Sciences
(172)
Multidisciplinary Sciences
(170)
Aged
(162)
Biochemistry & Molecular Biology
(157)
Technology
(148)
Child
(134)
Cell Biology
(126)
Mutation
(123)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Rural Livelihoods in China: Political economy in transition

PB1926: EFFICACY AND SAFETY OF ONCE DAILY (QD) VS TWICE DAILY (BID) ZANUBRUTINIB FOR PATIENTS WITH VARIOUS B-CELL MALIGNANCIES: A COMPARATIVE SUMMARY OF CLINICAL DATA AND EXPOSURE-RESPONSE ANALYSES

In vitro investigations into the roles of CYP450 enzymes and drug transporters in the drug interactions of zanubrutinib, a covalent Bruton's tyrosine kinase inhibitor

Prediction of bictegravir human pharmacokinetics from protein binding and in vitro-in vivo correlation

Design and synthesis of highly selective, orally active Polo-like kinase-2 (Plk-2) inhibitors

Antiviral Activity, Safety, and Pharmacokinetics of Bictegravir as 10-Day Monotherapy in HIV-1-Infected Adults

Migration in a transitional economy: Beyond the planned and spontaneous dichotomy in Vietnam

PB1926: EFFICACY AND SAFETY OF ONCE DAILY (QD) VS TWICE DAILY (BID) ZANUBRUTINIB FOR PATIENTS WITH VARIOUS B‐CELL MALIGNANCIES: A COMPARATIVE SUMMARY OF CLINICAL DATA AND EXPOSURE‐RESPONSE ANALYSES

The gathering storm: AIDS policy in China

Co-operative financial institutions and local development in China

Human and nonclinical disposition of [14C]bictegravir, a potent integrase strand-transfer inhibitor for the treatment of HIV-1 infection

Human pharmacokinetics prediction with an in vitro-in vivo correction factor approach and in vitro drug-drug interaction profile of bictegravir, a potent integrase-strand transfer inhibitor component in approved biktarvy® for the treatment of HIV-1 infection

Urban education differentiation and its socio-economic consequences: An internet–survey-based structural equation modeling analysis of new white collar workers in Nanjing, China

Guest Editor’s Preface

Protecting Mobile Livelihoods: Actors' Responses to the Emerging Health Challenges in Beijing and Tianjin

Abstract CT189: A first-in-human, phase 1a, dose-escalation study of BGB-10188, a phosphatidylinositol 3-kinase delta (PI3Kδ) inhibitor, + tislelizumab (anti-PD-1) in patients with solid tumors

The role of apoptosis in the development and function of T lymphocytes

Human Mass Balance and Metabolite Profiling of [14C]‐Pamiparib, a Poly (ADP‐Ribose) Polymerase Inhibitor, in Patients With Advanced Cancer

Comparisons of the success of racial minority immigrant offspring in the United States, Canada and Australia

P176 Clinical pharmacology of the HIV integrase strand transfer inhibitor bictegravir

Working with the homeless: The case of a non-profit organisation in Shanghai

Safety, efficacy, and pharmacokinetics of single-tablet elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide in virologically suppressed, HIV-infected children: a single-arm, open-label trial

THE ANTI-ISCHEMIC EFFECT OF RANOLAZINE CLOSELY PARALLELS ITS QTC-SHORTENING EFFECT IN PATIENTS WITH LONG-QT SYNDROME 3

Pharmacokinetic drug-drug interaction study of ranolazine and metformin in subjects with type 2 diabetes mellitus

Towards a More Systematic and International Economic Sociology

Suchergebnisse filtern